Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

36°
- Benton, AR (72018)
  Today
  
  Cloudy skies. High around 50F. Winds NE at 5 to 10 mph..
  
  Tonight
  
  Partly cloudy skies. Low 24F. Winds NNE at 10 to 15 mph.
  
  Updated: December 13, 2025 @ 5:22 am
- Full Forecast

- Site search

Home
News
- Local News
Sports
Obituaries
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Archives
Readers Choice 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Articles published by Clearmind Medicine Inc.

< Previous 1 2 3 4 Next >

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder

June 30, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market

June 27, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment

June 25, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

June 24, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder

June 23, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

June 12, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment

June 05, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts

May 20, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Announces Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction

May 12, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND SPRC

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

April 25, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites

April 23, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts

April 21, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior

April 17, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism

April 16, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder

April 10, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Announces the Publication of International Patent Application for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders

April 08, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment

April 01, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine’s FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones

March 21, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination

March 19, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND PLRZ

Clearmind Medicine Announces Initiation of First in Human Clinical Trial with CMND-100 in Alcohol Use Disorder Patients

March 18, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea

March 10, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND SPRC

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico

February 04, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Announces Shareholders Meeting Results

January 07, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

January 06, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office

January 02, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute

December 26, 2024

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial

December 24, 2024

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format

December 16, 2024

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site

October 10, 2024

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy

September 16, 2024

From Clearmind Medicine Inc.

Via GlobeNewswire

Tickers CMND

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

bentoncourier.com
321 North Market Street
Benton, AR 72018
Phone: 501-315-8228
Email: bcadmin@bentoncourier.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Benton, AR (72018)

Today

Tonight

Articles published by Clearmind Medicine Inc.

Sections

Services

Follow Us